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ABSTRACT Pulmonary surfactant (PS) dysfunction becauseof the leakageof serumproteins into the alveolar space could bean
operative pathogenesis in acute respiratory distress syndrome. Albumin-inhibited PS is a commonly used in vitro model for
studying surfactant abnormality in acute respiratory distress syndrome. However, the mechanism by which PS is inhibited by
albumin remains controversial. This study investigated the ﬁlm organization of albumin-inhibited bovine lipid extract surfactant
(BLES) with and without surfactant protein A (SP-A), using atomic force microscopy. The BLES and albumin (1:4 w/w) were
cospread at an air-water interface from aqueous media. Cospreading minimized the adsorption barrier for phospholipid vesicles
imposed by preadsorbed albuminmolecules, i.e., inhibition because of competitive adsorption. Atomic forcemicroscopy revealed
distinct variations in ﬁlm organization, persisting up to 40 mN/m, compared with pure BLES monolayers. Fluorescence confocal
microscopy conﬁrmed that albumin remained within the liquid-expanded phase of the monolayer at surface pressures higher than
the equilibrium surface pressure of albumin. The remaining albumin mixed with the BLES monolayer so as to increase ﬁlm
compressibility. Such an inhibitory effect could not be relieved by repeated compression-expansion cycles or by adding surfactant
protein A. These experimental data indicate a new mechanism of surfactant inhibition by serum proteins, complementing the
traditional competitive adsorption mechanism.
INTRODUCTION
The deﬁciency or dysfunction of pulmonary surfactant (PS)
causes severe respiratory diseases. Neonatal respiratory dis-
tress syndrome (RDS), the major disease of PS deﬁciency
worldwide, arises primarily from prematurity (1). It is esti-
mated that RDS affects up to 10% of all premature infants in
developed countries (2). In 2002, RDS affected an estimated
24,000 newborns in the United States alone (2). Displaying
symptoms similar to those of RDS, acute lung injury (ALI)
and its more severe form, acute respiratory distress syndrome
(ARDS), exhibit a rapid onset of respiratory failure that can
affect patients at any age (3). Acute respiratory distress syn-
drome affects;150,000 people per year in the United States,
and has a case fatality rate of 30–40% (4). The pathogenesis of
ARDS is not fully understood, but surfactant dysfunction is
believed to be an operative cause, induced by a primary
pathogenesis such as extensive lung inﬂammation, trauma,
severe pulmonary infection, oxygen toxicity, or radiation
damage (5,6).
Exogenous surfactant replacement therapy, in which either
synthetic or modiﬁed natural PS extracted from bovine or
porcine sources is delivered into the patients’ lungs, is es-
tablished as a standard therapeutic intervention for newborns
with RDS (7). Owing in part to surfactant therapy, the mor-
tality rate of premature infants in theUnited States attributable
to RDS fell by 24% in 1990, and has continued to decrease
(8,9). Inspired by their symptomatic similarity, surfactant
therapy was also attempted in the treatment of ARDS (10).
However, this has achieved limited success to date (11,12). It
was proposed that surfactant inactivation is partially respon-
sible for this unsatisfactory performance (5,6,11,13).
Surfactant inhibition (inactivation or dysfunction) refers to
those processes that decrease or abolish the normal biophys-
ical properties of PS (1,14). Such processes may 1), interfere
with phospholipid (PL) adsorption to form a functional ﬁlm
that decreases surface tension to 20–25mN/m, 2), prevent the
ﬁlm from reaching low surface tensions (,5 mN/m) upon
compression, or 3), impair the readsorption or reinsertion of
PL vesicles during expansion (14). A number of substances
were reported to inhibit PS, including serum proteins, unsat-
urated membrane PL, lysophospholipids, unsaturated free
fatty acids, meconium, and supraphysiological levels of
cholesterol (1,6,13–15).
In vitro biophysical studies established two distinct inhi-
bition mechanisms: inhibition attributable to serum proteins
via competitive adsorption, and inhibition attributable to un-
saturated and other lipids through mixing with and ﬂuidizing
otherwise stable PL ﬁlms (14,16). The competitive adsorption
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mechanism stipulates that surface-active serum proteins, such
as albumin and ﬁbrinogen, compete with PL for space at the
air-water interface. This inhibition mechanism was ﬁrst pro-
posed by Holm et al. and by Tabak and Notter, based on early
studies of surfactant inhibition using the Langmuir-Wilhelmy
balance (LWB) and the pulsating bubble surfactometer (PBS)
(16–19). These authors found that PS adsorption was in-
hibited when mixed with albumin before exposure to an air-
water interface. When the adsorption barrier was removed
either by spreading PS on top of an albumin-containing sub-
phase (19), or by spreading PL and albumin alternately at the
air-water interface (17), no inhibitory effects were found.
These tensiometric studies suggested that albumin and other
serum proteins, when present in the subphase, can inhibit PS
by adsorbing more rapidly to the air-water interface. Once
adsorbed, the protein molecules exclude PL vesicles from
entering the interface by creating a steric or electrostatic en-
ergy barrier (20,21). This inhibitionmechanismwas proven to
be operative, at least in vitro, by directly imaging PL ad-
sorption in the presence of albumin, using Brewster angle
microscopy (20) and ﬂuorescence microscopy (22,23). In
keeping with this view, low-concentration surfactant injected
under preadsorbed albumin ﬁlms, or mixed with albumin in
the subphase, adsorbs slowly (19,20,24,25). Also consistent
with competitive adsorption is the experimental observation
that inhibition attributable to serum proteins can be overcome
by increasing surfactant concentration (16), by adding sur-
factant protein A (SP-A) (26–28), or by adding carbohydrate
polymers (20,21,23,25,29). These approaches enhance the
adsorption rate of the PL vesicles of PS, and thus overcome
serum protein competition for the air-water interface.
Despite its success in interpreting in vitro inhibition of PS
by albumin and other serum proteins, the relevance of the
competitive adsorption mechanism to ARDS remains uncer-
tain. Indeed, leakage of serum proteins into the alveolar space
because of an impaired blood-air barrier is an early event in
the pathogenesis of ARDS (13). However, the levels of these
serum proteins relative to surfactant PL in the alveolar lining
layer of injured lungs are not unambiguously established.
Biophysical studies in vitro demonstrated that with surfactant
levels of 3 mg/mL, no obvious inhibitory effects were noted
with even eightfold greater albumin levels (16). It was also
found that the adsorption or spreading of high-concentration
PS (i.e., 27 mg/mL) was not signiﬁcantly inhibited, even in
the presence of high-concentration albumin (30).
More recent studies on surfactant PL bilayers and mono-
layers provided evidence that molecular interactions or
binding between PL and serum proteins may contribute to
surfactant inhibition (31–33). These suggestions are consis-
tent with the views of Seeger et al. during early studies of
surfactant inhibition (34). These authors demonstrated that
ﬁbrin, generated from ﬁbrinogen, inhibited surfactants from
attaining low surface tensions by forming insoluble com-
plexes, thus suggesting speciﬁc interactions between ﬁbrin
and PL in these surfactants.
The effect of SP-A in overcoming surfactant inhibition
because of serum proteins is also unclear. Surfactant protein
A is absent from all therapeutic surfactant preparations cur-
rently on the market. It is known that adding SP-A to lipid
extract surfactants in vitro increased their resistance to inhi-
bition because of serum proteins (26–28) and meconium
(28). In animal experiments, surfactants containing SP-A
showed higher resistance to inhibition than those without
SP-A (28,35–37).
Here, we studied albumin-inhibited bovine lipid extract
surfactant (BLES) ﬁlms with and without SP-A, using atomic
force microscopy (AFM). Albumin and BLES were cospread
at the air-water interface of a LWB from aqueous media.
Cospreading minimized (if not completely eliminated) the
adsorption barrier imposed by preadsorbed albumin mole-
cules on PL vesicles, i.e., inhibition attributable to competi-
tive adsorption. It was found that BLES ﬁlms were
signiﬁcantly inhibited by the cospread albumin, as indicated
by increased ﬁlm compressibility. This inhibition was not
mitigated by repeated compression-expansion cycles. AFM
revealed variations in ﬁlm organization from a surface
pressure (p) of 20–40 mN/m, compared with pure BLES
monolayers. These variations were attributable to albumin
molecules that remained at the interface and mixed with the
BLES ﬁlms, as revealed by ﬂuorescence confocal micros-
copy. It was also found that adding SP-A did not counteract
the inhibition because of cospread albumin, which indicates a
primary role of SP-A in reversing inhibition by enhancing PL
adsorption. These experimental data may indicate a new
mechanism of surfactant inhibition because of serum pro-
teins, and may have implications in the further development
of surfactant therapy for treating ARDS.
MATERIALS AND METHODS
Materials
The BLES (BLES Biochemicals, London, Ontario, Canada) and human SP-A
were described in detail previously (38). Brieﬂy, BLES contains all of the PL
in natural surfactant and hydrophobic surfactant proteins (SP-B and SP-C),
whereas it is devoid of hydrophilic surfactant proteins (SP-A and SP-D) and
cholesterol. The BLES was diluted to 5 mg/mL, using a saline buffer of 0.9%
NaCl, 1.5 mMCaCl2, and 2.5 mMHEPES at pH 7.0. The SP-A was added to
BLES at 2.5% relative to the weight of PL in the BLES.
Bovine serum albumin (BSA) (minimum 99%, essentially globulin and
fatty acid-free) and ﬂuorescein isothiocyanate (FITC)-labeled BSA were
purchased from Sigma Chemical Co. (St. Louis, MO) and used without
further puriﬁcation. An albumin concentration of 20 mg/mL was used. This
concentration is approximately half of the albumin concentration in serum,
and is close to the average albumin concentration in the alveolar ﬂuid of
ARDS patients as reported by Ishizaka et al. (39).
Langmuir-Wilhelmy balance
The spreading, compressing, and Langmuir-Blodgett (LB) transfer of sur-
factant ﬁlms was conducted in an LWB (m-Trough, Kibron, Helsinki, Fin-
land) at room temperature (24 6 1C). This trough contains a ;90 mL
subphase, and has an operational surface area of ;125 cm2. Detailed de-
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scriptions of the experimental procedures can be found elsewhere (38).
Brieﬂy, cospreading BLES and albumin was achieved by depositing tiny
droplets of aqueous mixtures of 5 mg/mL BLES, with and without 2.5 wt %
SP-A, and 20 mg/mL BSA, uniformly throughout the air-water interface. For
the sake of comparing ﬁlm compressibility, the amounts of spread PL were
the same as those for preparing BLES ﬁlms without albumin (38), i.e., 20 mL
for BLES-albumin without SP-A (containing 100 mg PL), and 10 mL for
BLES-albumin with SP-A (containing 50 mg PL). It was shown that with the
addition of SP-A, smaller amounts of spread PL were required to reach the
same p (38).
It should be noted that when spread from aqueous media, it is possible for
some PL vesicles to penetrate the air-water interface, instead of directly
spreading, and to adsorb back with time. Therefore, cospreading BLES and
albumin at the air-water interface cannot completely eliminate the process of
competitive adsorption. However, taking into account the extremely small
volumes of spreading and the relatively large volume of subphase, the chance
that surface active material lost in the subphase readsorbs to the interface is
small (40). Hence, the amount of material that is ﬁnally retained at the interface
would largely depend on the initial incorporation/adsorption efﬁciency (40).
Our previous studies showed that aqueous BLES samples at the studied
concentration (i.e., 5 mg/mL) have a high adsorption efﬁciency (38). This is
likely because of the high PL concentration, the hydrophobic surfactant pro-
teins in BLES (SP-B/C), and the procedure of spreading from the airside,
which minimizes the thermodynamic barrier for PL vesicles ‘‘unzipping’’ in
water (14,41). Adsorption of BLESwould be enhanced further by the addition
of SP-A (38). Consequently, the effect of competitive adsorption in the co-
spread BLES-albumin ﬁlms would be expected to be relatively small.
The spread ﬁlms were compressed at a rate of 30 mm2/s, i.e., at 0.24% of
initial area per second. Because the exact amount of material at the interface
is unknown, isotherms were expressed as the percentage of the initial area.
The ﬁlms at the air-water interface were transferred to freshly cleaved mica
surfaces atp of 20, 30, 40, and 45 mN/m, at a rate of 2 mm/min, using the LB
technique. The transfer ratios at p above 20 mN/m are much greater than 1,
likely arising from losses of monolayer materials because of the collapse of
albumin monolayers (at 30 and 40 mN/m) and PL monolayers (at 45 mN/m).
For ﬂuorescence imaging, BLES-albumin (1:4 w/w) ﬁlms with 1% FITC-
BSA were deposited at 30 mN/m onto glass coverslips.
Atomic force microscopy
Topographical AFM images were obtained using a Nanoscope III scanning
force multimode microscope (Digital Instruments, Santa Barbara, CA)
within 2 h of deposition. Samples were scanned with a J-type scanner, using
the contact mode in air. A silicon nitride cantilever with a spring constant of
0.12 N/m was used. The scan rate was 1 Hz, and the force exerted on the
samples was set at ;10 nN by adjusting the deﬂection setpoint. Section,
roughness, and grain analyses of AFM images were performed using
Nanoscope III software (version 5.12r3, Digital Instruments). Scion Image
(Scion, Frederick, MD) was used to quantify the areas and sizes of domains
in the AFM images. Quantiﬁcation results are presented as average 6 SD,




Fig. 1 shows the spreading (Fig. 1 A) and compression (Fig.
1 B) isotherms of BLES-albumin (1:4 w/w) ﬁlms. (A com-
pression isotherm of a representative pure BLES ﬁlm is also
shown in Fig. 1 B as a reference. For reasons of comparison,
this isotherm is shifted to the right to coincide with the onset
of compression isotherms of BLES-albumin ﬁlms.) Spread-
ing 20-mL samples (i.e., 100 mg BLES 1 400 mg albumin)
quickly increased p to an equilibrium value of ;20 mN/m,
corresponding to the equilibrium spreading pressure (pe) of
albumin (22,25,42). Compared with BLES ﬁlms formed
by the same amount of PL (Fig. 1 B), the cospread BLES-
albumin ﬁlms show higher ﬁlm compressibility (Cm¼(1/A)
(dA/dp)). As summarized in Table 1, the compressibility of
BLES-albumin ﬁlms is nearly ﬁvefold that of BLES ﬁlms at
20 mN/m. The compressibility decreases with increasing p,
and approaches the compressibility of BLES ﬁlms at 40mN/m.
The increase in ﬁlm compressibility because of cospread
albumin indicates an inhibition of the dynamic surface ac-
tivity of BLES ﬁlms, i.e., larger-area reductions are needed to
increase p. Cospreading BLES and albumin at the interface
minimizes the adsorption barrier for PL vesicles imposed by
preadsorbed albumin molecules. Therefore, the inhibitory
FIGURE 1 Spreading (A) and compression (B) isotherms of BLES-
albumin ﬁlms. Films were spread on ultrapure water from aqueous suspen-
sions of 5 mg/mL BLES and 20 mg/mL albumin at room temperature.
Spreading 20-mL samples yields a stable p of ;20 mN/m. Films were
compressed at a rate of 30 mm2/s, and were LB-transferred at 20, 30, and
40 mN/m. Spreading 30-mL samples allows LB transfer at 45 mN/m. A
compression isotherm of pure BLES ﬁlm spread from 20-mL 5 mg/mL
BLES is shown as a reference. For reasons of comparison, this compression
isotherm is shifted to the right to coincide with the initial p of the
compression isotherms of BLES-albumin ﬁlms.
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effect depicted in Fig. 1 may imply a new inhibition mech-
anism other than competitive adsorption.
Limited by mechanical design, the LWB used in this study
can only reach a minimum surface area of 15–20%, which
restricts the maximump for LB transfer. To transfer LB ﬁlms
at p higher than 40 mN/m, 30-mL samples (i.e., 150 mg
BLES 1 600 mg albumin) were spread. This increased the
rate at which equilibrium was attained but not the pe of al-
bumin, indicating that the air-water interface was already
saturated with albumin when 20-mL samples were spread.
With this higher spreading amount, the compression iso-
therms became steeper, and allowed amaximump of 45mN/m
for LB transfer with our LWB. This p corresponds to the
middle of a plateau in the compression isotherms. Further
increasing the spreading amount did not signiﬁcantly vary the
shape of the compression isotherms (results not shown). It is
worth stressing that the shape of the compression isotherms
of the BLES-albumin ﬁlms depends on the initial amount of
spreading (20 vs. 30 mL in Fig. 1). In other words, the change
in ﬁlm composition (i.e., PL/albumin molecular ratio) upon
compression is dependent on the initial amount of spreading.
This variation in ﬁlm composition of cospread ﬁlms upon
compression will be discussed in detail.
It should be noted that the increase in p during the com-
pression of cospread ﬁlms was mainly attributable to BLES
rather than albumin. As shown in Fig. 2, adsorbed albumin
ﬁlms can only regulatepwithin a narrow range between;20
and ;32 mN/m with the same compression rate used for
BLES-albumin ﬁlms.
Fig. 3, A–D, shows characteristic AFM images for the
BLES-albumin ﬁlms. At 20 mN/m (Fig. 3 A), the ﬁlm was
transferred without compression. The AFM image is of a ﬂat,
featureless pattern with a height variation of ,0.1 nm. This
pattern closely resembles pure albumin ﬁlms at their pe (Fig.
2, inset). The presence and homogeneity of albumin mole-
cules on the mica surface were conﬁrmed using FITC-labeled
BSA (results not shown). This AFM observation is consistent
with tensiometric measurements (Fig. 1 A), and suggests that
after cospreading, the air-water interface is covered primarily
by a saturated amount of albumin molecules.
It should be noted that the root mean-square roughness of
AFM images in Figs. 2 and 3 A, measured over areas of 53 5
mm, is 0.18 nm and 0.19 nm, respectively. These values are
lower than the roughness of human serum albumin (HSA)
monolayers reported previously (43). Using the tapping
mode AFM, Sheller et al. (43) measured the roughness of
homogenous HSA monolayers as 0.32–0.35 nm. This dif-
ference likely arises from the different scanning modes used
in these two studies. The contact-mode scanning used in our
study is more susceptible to tip effects when scanning soft
samples such as albumin. As a result of pressing the soft
samples, the thickness and roughness measured in the contact
model can be smaller than the actual values. Wemeasured the
roughness of BSA monolayers, using the tapping model, as
0.37–0.39 nm, which is close to previous measurements.
Nevertheless, this artifact due to tip effects will not signiﬁ-
cantly affect our interpretations and comparisons between
samples, because the contact mode was used throughout this
study.
At 30 mN/m (Fig. 3 B), a number of microscale hole-like
domains appear. Topographic analysis revealed that both the
interiors and exteriors of these domains are heterogeneous
(Fig. 3 b). As detailed in Fig. 3 B, insets, the interiors of these
domains contain grains that are 176 10 nm in size and 0.76
0.3 nm higher than their neighbors. The exteriors of these
domains are also heterogeneous, with a height variation of up
TABLE 1 Film compressibility (mN/m)1 of different






BLES 1 SP-A 1
albumin
20 0.016 6 0.006 0.077 6 0.008 0.017 6 0.006 0.078 6 0.010
30 0.014 6 0.002 0.044 6 0.004 0.015 6 0.002 0.063 6 0.006
40 0.017 6 0.001 0.021 6 0.004 0.021 6 0.003 0.035 6 0.007
For reasons of comparison, ﬁlms with or without albumin were prepared
with the same amount of BLES. The BLES ﬁlms were prepared using
100-mg BLES samples. The BLES ﬁlms with 2.5% SP-A were prepared using
50-mg BLES samples. Four times more albumin by weight was cospread
with the corresponding BLES and BLES 1 SP-A samples.
FIGURE 2 Typical compression-expansion isotherm of an adsorbed al-
bumin ﬁlm at the air-water interface. (Inset) Characteristic AFM topographic
image (20 3 20 mm) at the equilibrium surface pressure of albumin (i.e.,
;20 mN/m). The vertical distance between the two arrowheads in the cross-
sectional proﬁle is 0.08 nm.
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to 2 nm. The heterogeneity of AFM images generates difﬁ-
culty in accurately estimating the depth of these domains
based only on a cross-sectional analysis. (Hence, the vertical
distances between arrowheads shown in the cross-sectional
proﬁles in Figs. 3 and 5 are only indicative. The selection of
arrowhead positions is neither speciﬁc nor sensitive.) Nev-
ertheless, it appears that these domains are shallow, i.e.,
generally ,0.5 nm lower than their surroundings. The hole-
like domains cover 12% 6 3% of total surface area, slightly
more than the area of microscale PL domains found in BLES
monolayers at the same p (38).
At 40 mN/m (Fig. 3 C), the hole-like domains are desta-
bilized, as indicated by a decrease in total domain area to
8%6 2%. In addition, as shown in Fig. 3 C, inset, many nano-
scale holes with sizes ranging from 200–300 nm appear in the
ﬁlm. However, because of the heterogeneity of AFM images, it
FIGURE 3 Characteristic AFM topo-
graphic images of BLES-albumin ﬁlms.
(A–C) Scan area is 203 20mm. (D) Scan
area is 10 3 10 mm. (A) 20 mN/m. (B)
30 mN/m. (C) 40 mN/m. (D) 45 mN/m.
(a–d) Height variation along scanning
line drawn in corresponding topograph-
ical image. The vertical distance between
arrowheads is indicated in cross-sectional
proﬁle. (B, insets) Heterogeneity inside
and outside the hole-like domains, respec-
tively. Bars in insets represent 200 nm. (C,
inset) An enlargement of nanoscale holes,
indicated by arrows. Bar in inset represents
1 mm.
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is difﬁcult to estimate accurately the area occupied by these
nanoholes.
At 45 mN/m (Fig. 3 D), i.e., in the plateau region of the
compression isotherms (Fig. 1 B), multilayer structures 4.5–
5.0 nm in height and ;0.1 mm in diameter are observed.
These multilayers, accounting for ;1 PL bilayer stack (44),
cover 16% 6 4% of the surface area.
BLES with SP-A and albumin
Fig. 4 shows the spreading (Fig. 4 A) and compression (Fig.
4 B) isotherms of BLES-albumin (1:4) ﬁlms with the addition
of 2.5% SP-A relative to the PL in BLES. (A compression
isotherm of a representative BLES and SP-A ﬁlm is also
shown in Fig. 4 B as a reference.) Spreading 10-mL or 15-mL
samples increased p to the pe of albumin. It was found that
the addition of SP-A (2.5%) cannot reverse the inhibition
attributable to cospread albumin. Rather, the addition of SP-A
slightly increased the ﬁlm compressibility (Table 1). In-
creasing the SP-A to 5% and 10% did not signiﬁcantly vary
the ﬁlm compressibility (results not shown).
Fig. 5, A–D, provides characteristic AFM images of BLES
ﬁlms with SP-A and albumin. These images are of combined
features of BLES ﬁlms with SP-A (38) and with albumin
(Fig. 3), respectively. At 20 mN/m (Fig. 5 A), i.e., before ﬁlm
compression, the ﬁlm appears to be ﬂat and rather featureless,
except for a few isolated bright (high) spots. These spots
appear to be SP-A octadecamers or aggregates formed by SP-A
self-association (38). At 30 mN/m (Fig. 5 B), hole-like do-
mains appear with most of the domain boundaries associated
with SP-A aggregates. Most of the SP-A aggregates appear at
the right boundaries of these lower domains. This might in-
dicate an artifact because of tip effects: the AFM tip dragged
the SP-A aggregates down the scanning direction (from left
to right), so that most of these aggregates drifted to the right
and ﬁnally stuck at the boundaries of the holes. A close look
at these individual SP-A aggregates revealed that they pos-
sessed diamond or rectangular shapes. This can also be at-
tributed to artifacts because of dirty or blunt tips. Such
artifacts were not previously evident when studying mono-
layers of BLES and SP-A (38). However, the AFM tips may
be more susceptible to contamination when scanning albu-
min samples, because this protein can easily stick to the tips.
These artifacts attributable to AFM tips do not likely alter the
overall structures of the phospholipid phase separation,
which is the main interest of this study.
At 40 mN/m (Fig. 5 C), more bright spots appear, but the
majority of these seem to be squeezed out of the PL mono-
layer, which is consistent with our previous ﬁnding for BLES
and SP-A monolayers (38). Moreover, at 40 mN/m, the
originally lower hole-like domains appear to reverse their
height, to become ‘‘islands’’ with a deep halo. At 45 mN/m
(Fig. 5 D), multilayers with a maximum height of ;14 nm
appear.
DISCUSSION
Albumin-induced variations in surface activity
The competitive adsorption mechanism stipulates that sur-
factant inhibition because of serum proteins, such as albumin,
arises from the ability of these proteins to monopolize the
surface, thereby impeding the adsorption or spreading of
surfactant PL. Hence, this mechanism predicts that a surfac-
tant ﬁlm directly spread at an air-water interface to a particular
p should not be affected by albumin, whether the protein was
dissolved in the subphase or was spread at the interface (19).
However, our study shows that cospreadBLES-albumin ﬁlms
at the air-water interface are signiﬁcantly inhibited, at least
during the ﬁrst compression (Fig. 1).
FIGURE 4 Spreading (A) and compression (B) isotherms of BLES-
albumin ﬁlms with SP-A. Films were spread from an aqueous suspension
of 5 mg/mL BLES with 2.5% SP-A and 20 mg/mL albumin. The amounts
spread were usually 10 mL, unless high deposition pressure was required. To
deposit a ﬁlm at 45 mN/m, 15-mL samples were spread. The subphase and
rate of compression are the same as in Fig. 1. A compression isotherm of
BLES and SP-A ﬁlms without albumin is shown as a reference. This ﬁlm
was prepared by spreading 10-mL 5 mg/mL BLES with 2.5% SP-A. For
reasons of comparison, this compression isotherm is shifted to the right to
coincide with the initial p of the compression isotherms of the ﬁlms with
albumin.
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The ability of albumin to interfere with the dynamic surface
activity of BLES was further investigated with a large
Langmuir trough (Nima Technology, Coventry, UK). With a
larger operational surface area (;750 cm2), this trough re-
moves the restriction in area reduction encountered by the
small trough used in Fig. 1. Therefore, more complete com-
pression isotherms can be obtained. This trough was used to
conduct multiple compression-expansion cycles of BLES-
albumin (1:4) ﬁlms. As shown in Fig. 6, the isotherm for the
ﬁrst compression reproduces that obtained using the small
trough (Fig. 1 B). The ﬁlm compressibility decreases only
slightly from the ﬁrst to the second compression, but remains
relatively unchanged during the next ﬁve repeated compres-
sions. This indicates that repeated compression-expansion
cycles cannot counteract surfactant inhibition because of the
cospread albumin. This ﬁnding is rather surprising, because
FIGURE 5 Characteristic AFM topo-
graphic images of BLES-albumin ﬁlms
with SP-A. (A–C) Scan area is 20 3 20
mm. (D) Scan area is 10 3 10 mm. (A)
20 mN/m. (B) 30 mN/m. (C) 40 mN/m.
(D) 45 mN/m. (a–d) Height variation
along scanning line drawn in correspond-
ing topographical image. The vertical dis-
tance between arrowheads is indicated in
cross-sectional proﬁle. Heights of bright
spots in these images vary from;4 nm to
more than 10 nm, as indicated in cross-
sectional proﬁles.
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previous studies showed that albumin molecules can be re-
moved from the air-water interface by simply overspreading a
dipalmitoyl phosphatidylcholine (DPPC) monolayer (42), or
by a few compression-expansion cycles when excess sur-
factant vesicles exist in the subphase (18).
Although inhibition is not mitigated by repeated com-
pressions, the compressibility of BLES-albumin ﬁlms de-
creases during each compression (Table 1 and Fig. 6). This
implies a gradual reﬁning of the ﬁlms by squeezing out al-
bumin molecules from the interface. At 40 mN/m, the com-
pressibility of cospread ﬁlms approaches that of pure BLES
ﬁlms, indicating nearly complete removal of albumin mole-
cules. As shown in Fig. 6, the isotherms undergo a plateau
between 40–50 mN/m, and then rise steeply after passing this
plateau. This pattern closely resembles pure BLES ﬁlms in
the same p range (38). However, the ﬁlm compressibility
increases again at the onset of a subsequent compression
(Fig. 6). This indicates readsorption of albumin molecules
into the BLES monolayers during ﬁlm expansion. Note that
thep at the end of expansion, i.e., the onset of recompression,
is lower than the pe of albumin (i.e., ,20 mN/m). Warriner
et al. (22) showed that albumin in the subphase interferes
with the readsorption and respreading of collapsed PL ﬁlms
at a p of 20 mN/m or lower. Our experiments further suggest
that albumin molecules can remain at, or reenter, an interfa-
cial PS ﬁlm at a low p range (,40 mN/m), even though they
are squeezed out at higher p. By remaining at the interface,
albumin can inhibit surfactant ﬁlms by increasing ﬁlm
compressibility. This point of view is further supported by
directly imaging variations in ﬁlm organization, as discussed
below.
Albumin-induced variations in ﬁlm organization
The albumin-induced variations in ﬁlm compressibility are
consistent with variations in ﬁlm organization. AFM revealed
two distinct variations in monolayer topography between
BLES (38) and BLES-albumin ﬁlms, even though the same
amount of BLES was spread in both cases. First, at 20 mN/m,
pure BLES monolayers showed a clear separation of tilted-
condensed (TC) and liquid-expanded (LE) phases, as dem-
onstrated by the formation of micrometer-sized TC domains
(i.e., microdomains) that are generally 0.6–1.0 nm higher than
the surrounding LE phase (38). In contrast, in the presence of
albumin, no TC domains can be found at this p (Fig. 3 A).
Second, when pure BLESmonolayers were compressed from
30–40 mN/m, the microdomains appeared to be destabilized,
as indicated by a decrease in domain area (38). Accompanying
the decrease in microdomains was an increase in nanometer-
sized TC domains (i.e., nanodomains) (38). The same trend in
the p-dependent evolution of microdomains was found in
BLES-albumin ﬁlms. However, the originally higher TC
domains in BLES monolayers became somewhat lower than
their surroundings, and apparent heterogeneity occurred both
inside and outside the domains (Fig. 3, B and C). The hetero-
geneity of AFM images prevented the explicit detection of any
nanoscale features of the ﬁlm at 30 mN/m. However, nano-
holes were evident at 40 mN/m (Fig. 3 C), although their sizes
were relatively larger than the nanodomains found in BLES
monolayers (38).
Similar variations in ﬁlm organization were reported by
Nag et al. (33) for BLES ﬁlms mixed with fetal calf serum
(BLES-serum, 1:0.5 w/w). Nag et al. (33) hypothesized that
the formation of hole-like domains suggested that the serum
selectively interacted with the TC-phase PL, thus perturbing
the lipid packing in TC domains (33). The heterogeneity of
domains is also consistent with our previous studies of PS
lavaged from excised rats’ lungs subjected to injuriously high-
stretch ventilation (45). A direct comparison of our study’s
BLES-albumin ﬁlms with the surfactant obtained from in-
jured lungs, however, is complicated insofar as the contents of
both serum proteins and cholesterol were found to be in-
FIGURE 6 Repeated compression-expansion isotherms of a cospread
BLES-albumin (1:4 w/w) ﬁlm. Cycles 1–3 are shown with complete
compression-expansion isotherms. Cycles 4–6 are shown with only com-
pression branches. These experiments were conducted in a large Langmuir
trough with an operational area of ;750 cm2. The compression isotherms
shifted to the left with repeated compressions, indicating loss of surface
active material from the interface. Despite the shift, the shape of these
compression isotherms, i.e., the ﬁlm compressibility, only varied slightly
with an increasing number of compressions. (Inset) Compressibility (Comp.)
at 20, 30, and 40 mN/m of the ﬁrst compression and the average of sub-
sequent ﬁve compressions.
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creased in the injured lungs (45). Nevertheless, it appears
clear that surfactant inhibition by serum proteins is associated
with variations in ﬁlm organization, from a conﬁguration in
which relatively homogeneous island-like TC domains are
embedded within a LE phase, into an organization where
heterogeneous hole-like domains are distributed within a
relatively rough matrix.
Because compressibility measurements suggested that al-
bumin molecules can only be completely squeezed out from
the interface at p higher than 40 mN/m, the variations in ﬁlm
organization observed atp of 20–40 mN/mmay be attributed
to albumin molecules remaining at the interface. To under-
stand further the role of albumin molecules in varying the
ﬁlm organization, we examined BLES-albumin ﬁlms with
1% FITC-labeled BSA, using ﬂuorescence confocal mi-
croscopy (FCM) (Zeiss LSM 510). As shown in Fig. 7, FCM
images of BLES-albumin ﬁlms conﬁrm that albumin remains
at the interface at 30 mN/m. The dark dye-excluding domains
shown in Fig. 7 are consistent with the hole-like domains
revealed by AFM at the same p (Fig. 3 B), although with
larger sizes, possibly because of the different substrates used
for LB transfer.
Fig. 7 shows that albumin molecules preferentially parti-
tion into the LE phase of the BLESmonolayers, which argues
against speciﬁc interactions between albumin and the TC-
phase PL. Hence, the manner by which albumin alters the
ﬁlm organization remains unknown. To address this ques-
tion, we measured the absolute thicknesses of albumin and
BLES monolayers by scraping away parts of the monolayers
using AFM tips with a large force and a high frequency, as
described by Dufrene et al. (46). The ﬁlm thickness could
then be determined by measuring the stepwise depth of
monolayers relative to the mica surface. (A detailed de-
scription of the experimental methods can be found in the
Supplementary Material, Data S1.) The thickness of albumin
monolayers (at 20 mN/m) was measured to be 3.06 0.5 nm,
which is in good agreement with previous measurements
(43,47). This value is smaller than the theoretical mono-
molecular dimension of albumin, when it assumes a side-on
position at the interface (i.e., ;4 nm). As mentioned above,
this difference could be due to an artifact, because AFM tips
press soft samples, such as proteins, so that they yield smaller
measurements than the actual thickness of the samples. Al-
ternatively, this may be a consequence of albumin molecules
undergoing conformational changes or structural deforma-
tions after adsorbing to the air-water interface (43). The
thickness of BLES monolayers (LE phase at 30 mN/m) was
measured at 2.0 6 0.3 nm. It was reported that the thickness
of DPPC bilayers in the liquid-crystalline phase is 3.7–4.3
nm, and 4.7 nm for bilayers in the gel phase (44). Accord-
ingly, the monolayer thickness of DPPC may be approxi-
mated as 2 nm by assuming a single leaﬂet of these bilayers.
Our AFM measurements are consistent with these data.
Given that albumin monolayers are slightly thicker than
BLES monolayers, and taking into account the tensiometric
measurements (Fig. 1) and FCM observations (Fig. 7), the
ﬁlm organization of BLES-albumin ﬁlms revealed by AFM
may be explained by the diagram in Fig. 8). (Fig. 8 illustrates
ﬁlm organization at the air-water interface. The topographic
analysis by AFM, however, was conducted on LB ﬁlms
transferred to solid supports.)
First, assuming a similar ﬁlm incorporation efﬁciency,
cospreading BLES-albumin 1:4 by weight would result in a
mixed monolayer with a molecular ratio of ;20 PL to 1 al-
bumin (Fig. 8 A). By assuming the one-dimensional molec-
ular dimensions of PL and albumin to be 1 nm (headgroup)
and 10 nm (side-on position), respectively, the molecular
area ratio between PL and albumin should be ;1:100. This
leads to a surface-area ratio of;1:5 between PL and albumin
after cospreading. Hence, the p of the mixed monolayer is
predominantly controlled by albumin, as indicated by the
rapid attainment of the pe of albumin (;20 mN/m) after
cospreading (Fig. 1 A). The PL molecules are expected to be
in a relatively homogeneous LE phase, where the headgroups
of PL molecules are translationally disordered, and the fatty-
acid chains are conformationally disordered (48). This ﬁlm
organization results in the ﬂat, featureless topographic char-
acteristics observed immediately after cospreading (Fig. 3 A),
similar to the structure of pure albumin monolayers (Fig. 2,
inset).
Second, when p is increased beyond the pe of albumin
(;20 mN/m) but below the pe of PL in BLES (;45 mN/m),
the albumin molecules gradually leave the interface, but the
PL molecules remain (Fig. 8 B). This results in an increased
FIGURE 7 A ﬂuorescence confocal microscopy image of BLES-albumin
(1:4 w/w, with 1% FITC-labeled BSA) ﬁlms. Scan area is 50 3 50 mm.
Films were prepared by the same procedures as in Fig. 1. The LB ﬁlms were
deposited onto glass coverslips at 30 mN/m. This image demonstrates that
albumin coexists with BLES within the LE phase of the monolayer at a p
higher than the pe of albumin (i.e., .20 mN/m).
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PL/albumin molecular ratio at the interface (as indicated by
the decrease in ﬁlm compressibility shown in Table 1). The
actual PL/albumin molecular ratio at a certain p depends on
the initial amount of spreading (i.e., total numbers of PL and
albumin molecules at the interface before compression).
Consequently, compression isotherms of BLES-albumin
ﬁlms spread from 20-mL and 30-mL samples, although an-
chored at the same initial p of 20 mN/m, show different ﬁlm
compressibilities (Fig. 1 B).
In contrast to the collapse of the albumin monolayer, the
PL monolayer increases its packing density upon ﬁlm com-
pression, leading to an LE-TC phase transition similar to the
phase transition of pure BLES monolayers (38). The TC do-
mains contain disaturated PL in a gel phase that excludes hy-
drophobic surfactant proteins (SP-B/C) and albumin (Fig. 7).
Because of the persistence of albumin molecules at the inter-
face, the TC domains are detected as sunken holes by AFM
(Fig. 3, B and C).
At p higher than 40 mN/m, nearly all albumin molecules
are removed from the interface, leaving a nearly pure BLES
monolayer, as indicated by the ﬁlm compressibility (Table
1 and Fig. 6), as discussed above. Another indication of the
removal of albumin involves the change of domain mor-
phology from holes to islands, as observed at 40 mN/m in
Fig. 5 C.
Third, when p is further increased beyond the pe of the PL
in BLES (;45 mN/m), the PL monolayer partially collapses
to form multilayers that consist of an interfacial monolayer
plus interconnected bilayers (Fig. 8 C) (38). The monolayer-
to-multilayer transition corresponds to the plateau at 40–50
mN/m in the compression isotherms (Fig. 6) (38,49). The
multilayer structures found at 45 mN/m (Fig. 3 D) show
smaller sizes and predominantly single-bilayer thicknesses,
compared with the larger sizes and multi-bilayer thicknesses
of BLES ﬁlms at 50 mN/m (38). This comparison conﬁrms
the growth of multilayer structures corresponding to p in-
crease in the uprising plateau region. This is consistent with
the nucleation-growth theory for the formation of compres-
sion-driven multilayers from an interfacial monolayer (i.e.,
two-dimensional to three-dimensional transition) (50).
Phospholipid-protein interactions: from general
physicochemical studies to pulmonary
surfactant inhibition
The interfacial molecular interactions between chemical
surfactants and proteins in general and between PL and al-
bumin in particular are well-documented because of their
importance in many biomedical and biotechnological appli-
cations, especially in food colloidal systems (51–53). The
interactions between proteins and PL monolayers are de-
pendent on the electrostatic charges of both the lipids and the
proteins and the p of monolayers.
It has long been known that proteins such as albumin can
penetrate PL monolayers at low p (usually no more than 20
mN/m) (54). It was also shown microscopically that protein
penetration is dependent on the phase of PL monolayers (55–
57). Albumin can coexist at the interface with pure PL (such
as DPPC) in the LE phase, but is squeezed out at higher p,
where the PL monolayer consists of a nearly homogeneous
TC phase (57). Such penetration and squeeze-out processes
appear to be driven by surface energetic and steric causes,
and no speciﬁc PL-protein interaction was found to be in-
volved (56). The DPPC monolayers show LE-TC phase
transition/coexistence in a narrow p range of 9–13 mN/m at
room temperature (48). In contrast, condensed domains in PS
ﬁlms start growing at ;10 mN/m (58,59), and LE-TC phase
coexistence persists at 40 mN/m (38) and likely even up to
FIGURE 8 Diagram of ﬁlm organization for cospread BLES and albumin
ﬁlms compressed at an air-water interface. Although the ﬁlm organization is
illustrated at the air-water interface, the topographic analysis by AFM was
conducted on LB ﬁlms transferred onto solid supports. The molecular
dimensions of PL (labeled P) and albumin are not strictly scaled. (A) Film
organization at 20 mN/m (i.e., pe of albumin). Immediately after cospread-
ing, the interfacial ﬁlm consists of both PL and albumin at a molecular ratio
of;20:1. The PL molecules are in a conformationally disordered LE phase,
and are underneath the albumin monolayer, which has a thickness of;3 nm.
Hence, AFM reveals a homogeneous ﬁlm. (B) Film organization in the
p range of ;20 to ;45 mN/m. In this p range, albumin molecules are
gradually squeezed out from the interface. The PL molecules, on the other
hand, increase packing density, thus undergoing the LE-TC phase transition.
The TC domains consist of closely packed, disaturated PL molecules in a gel
phase, excluding the albumin molecules. Hence, AFM reveals hole-like
domains with low depths. Because of disturbance by albumin molecules
(e.g., residual albumin trapped inside domains, or lipid-protein interactions),
both the interior and exterior of these domains are topographically hetero-
geneous. (C) Film organization at p higher than;45 mN/m (i.e., pe of PL in
BLES). In this p range, albumin molecules are largely squeezed out from the
interface. The PL molecules start to form multilayered structures by partial
collapse of the interfacial monolayer. Hence, AFM reveals features higher
than a monomolecular thickness. Although they have been squeezed out,
albumin molecules likely remain associated with the PL (not shown),
because they can readily readsorb upon ﬁlm expansion.
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near 70 mN/m (60). Consequently, it is expected that albumin
coexists with BLES in the LE phase to a p higher than 20
mN/m (Fig. 7).
The albumin molecules remaining at the interface may
suppress the normal PL phase transition in PS monolayers,
because the condensed domains have to grow at the expense
of compressing and displacing the protein layer. It is known
that proteins such as albumin at the interface can form a
strong, viscoelastic two-dimensional gel because of strong
intermolecular interactions (52). Consequently, in the pres-
ence of albumin, the normal phase separation in PS ﬁlms can
be disturbed to some degree, especially when the protein
layer is tightly packed. Evidence along this line requires
further investigation.
There is evidence that once squeezed out of the interface at
high p, proteins can remain associated with the lipid
monolayer by electrostatic or hydrophobic binding (51,52).
These attached albumin molecules or albumin-lipid com-
plexes can be effectively adsorbed back to the surface as p
decreases (51,52,61). These previous ﬁndings are in good
agreement with the deleterious effects of albumin shown in
Fig. 6, which were not mitigated after repeated compression-
expansion cycles, although squeeze-out was evident at the
high p of each compression. This view is consistent with the
ﬁndings of interactions/binding between albumin and PS
bilayers. Larsson et al. (31) and Nag et al. (32) showed that a
small amount of albumin altered the thickness and lipid order
of PL bilayers of BLES by binding tightly to the bilayers.
With a better understanding of the nature of these molecular
interactions, Fig. 8 could be amended accordingly to reveal
the molecular interactions/binding between albumin and PL
or surfactant-associated proteins (SP-B/C) in BLES.
The heterogeneity of BLES-albumin ﬁlms observed here
is also in good agreement with previous studies of mixed
surfactant-protein ﬁlms (53,57,61). For example, de Souza et al.
(61) showed that addition of albumin in nanomolar concen-
trations can signiﬁcantly increase the roughness of LB ﬁlms
of PL. The speciﬁc morphological variation was dependent
on the charge of the PL monolayers. De Souza et al. (61)
attributed the alternations in surface morphology to disturbed
lipid packing because of PL-protein interactions (61).
Effect of SP-A on albumin-induced
surfactant inhibition
Previous in vitro and in vivo studies demonstrated that a trace
of SP-A (i.e., 1–5 wt % relative to PL) can signiﬁcantly en-
hance the resistance of lipid extract surfactants to inhibition
due to a variety of substances, including albumin (26–28).
Our study, however, shows that SP-A from 2.5–10% added
to 5 mg/mL BLES cannot effectively reverse the inhibition
attributable to 20 mg/mL albumin (Fig. 4). The characteristic
AFM images obtained with and without SP-A show a similar
PL ﬁlm organization (Fig. 3 versus Fig. 5). Compared with
previously published data (26–28), this cannot be explained
by the stoichiometric ratios between surfactant PL, albumin,
and SP-A. The main difference between our work and pre-
vious studies involves the experimental design. In previous in
vitro studies, SP-A was mixed with surfactant preparations
and serum proteins in the subphase. In our study, however,
SP-A, BLES, and albumin were spread directly at the inter-
face. Our study thus suggests that SP-A reverses albumin-
induced inhibition largely by enhancing adsorption. This
view is consistent with the function of SP-A in the absence of
inhibitors (38). Unless excessive PL vesicles are available in
the subphase, SP-A cannot signiﬁcantly enhance the dynamic
surface activity of surfactant ﬁlms. In fact, the direct addition
of SP-A to the interface slightly increases the ﬁlm com-
pressibility (Table 1). This ﬁnding is analogous to the de-
stabilization effects of hydrophobic surfactant proteins on PL
monolayers reported by Lhert et al. (62).
Although not directly enhancing the surface activity of
interfacial monolayers, SP-A appears to play a role in stabi-
lizing multilayer structures, even in the presence of albumin.
The multilayer structures formed with SP-A are ;3-fold
higher than those formed without SP-A at the same p (Fig.
5 d versus Fig. 3 d). This is consistent with the ability of SP-A
to promote the formation of multilayer structures in the ab-
sence of albumin (38).
Physiological relevance to ARDS
Albumin spreading or cospreading with PS is not physio-
logically relevant to ARDS. A more relevant experimental
design would involve spreading surfactant at the interface,
and injecting albumin into the subphase (16,19,22). This
approach, however, would ‘‘contaminate’’ the subphase,
causing technical difﬁculties with AFM imaging. Previous
experiments using subphase injections showed that albumin
in the subphase is not very effective at penetrating a pre-
formed PS ﬁlm at p above 20 mN/m (16,19,22). In healthy
lungs, p likely varies between 70 mN/m to not much lower
than 40 mN/m (63,64). Therefore, although it normally exists
in the alveolar ﬂuid in small amounts (39), albumin does not
pose a threat under healthy conditions.
In ALI/ARDS, however, PS undergoes chemical alteration
due to oxidation, or physical dilution via pulmonary edema
(5,13,65). In addition, there are metabolic changes attribut-
able to inﬂammation (5,13). Schmidt et al. (66) reported that
the major PL and protein components of endogenous sur-
factant were signiﬁcantly reduced in ARDS patients. The
alveolar contents of DPPC, SP-A, SP-B, and SP-C were all
reduced to ;50% of healthy controls, and these levels re-
covered only slowly and incompletely during 8 days of ob-
servation (66). Signiﬁcantly reduced surface activity was
associated with this compositional degradation (66). Under
these conditions, albumin penetration could occur at the most
energetically favorable sites of impaired PS ﬁlms, e.g., those
places with decreased ﬁlm thickness, reduced lipid packing,
and altered electrical surface potential (14).
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In conclusion, this study suggests a new biophysical
mechanism for surfactant inhibition by serum proteins, such
as albumin. Albumin remains in the LE phase of surfactant
monolayers atp up to 40 mN/m, i.e., much higher than thepe
of albumin (;20mN/m).Bymixing and coexistingwith PL at
the interface, albumin increases ﬁlm compressibility. Hence,
a much greater reduction in area is required to achieve high p
(i.e., low surface tensions). Although albumin molecules are
squeezed out of the interface at higher p, they may remain
associated with the interface in such a way that they can
readily readsorb with decreasing p. Consequently, this in-
hibitory effect of albumin cannot be readily relieved by re-
peated compression-expansion cycles. It must be stressed that
this new mechanism of surfactant inhibition does not neces-
sarily contradict other inhibition mechanisms attributable to
serum proteins, such as competitive adsorption. Instead, it
complements the competitive adsorption mechanism by ad-
dressing an additional deleterious effect of albuminmolecules
once they enter the interface, a condition that is likely in ALI/
ARDS. It was also found that SP-A cannot effectively coun-
teract this inhibitory effect, indicating that SP-A reverses
surfactant inhibition primarily by enhancing PL adsorption,
rather than by directly altering lipid packing at the interface.
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